102 related articles for article (PubMed ID: 9072127)
1. [Protected bacteriologic brushing in patients with severe copd].
Zalacain R; Achótegui V; Pascal I; Camino J; Barrón J; Sobradillo V
Arch Bronconeumol; 1997 Jan; 33(1):16-9. PubMed ID: 9072127
[TBL] [Abstract][Full Text] [Related]
2. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.
Monsó E; Ruiz J; Rosell A; Manterola J; Fiz J; Morera J; Ausina V
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1316-20. PubMed ID: 7551388
[TBL] [Abstract][Full Text] [Related]
3. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
4. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study.
Cabello H; Torres A; Celis R; El-Ebiary M; Puig de la Bellacasa J; Xaubet A; González J; Agustí C; Soler N
Eur Respir J; 1997 May; 10(5):1137-44. PubMed ID: 9163659
[TBL] [Abstract][Full Text] [Related]
5. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
6. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
[TBL] [Abstract][Full Text] [Related]
7. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.
Miravitlles M; Espinosa C; Fernández-Laso E; Martos JA; Maldonado JA; Gallego M
Chest; 1999 Jul; 116(1):40-6. PubMed ID: 10424501
[TBL] [Abstract][Full Text] [Related]
8. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.
Zalacain R; Sobradillo V; Amilibia J; Barrón J; Achótegui V; Pijoan JI; Llorente JL
Eur Respir J; 1999 Feb; 13(2):343-8. PubMed ID: 10065679
[TBL] [Abstract][Full Text] [Related]
9. Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations.
Qvarfordt I; Riise GC; Andersson BA; Larsson S
Respir Med; 2000 Sep; 94(9):881-7. PubMed ID: 11001080
[TBL] [Abstract][Full Text] [Related]
10. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.
Patel IS; Seemungal TA; Wilks M; Lloyd-Owen SJ; Donaldson GC; Wedzicha JA
Thorax; 2002 Sep; 57(9):759-64. PubMed ID: 12200518
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy.
Murphy TF; Sethi S; Klingman KL; Brueggemann AB; Doern GV
J Infect Dis; 1999 Aug; 180(2):404-9. PubMed ID: 10395856
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and chronic colonization of
Tufvesson E; Markstad H; Bozovic G; Ekberg M; Bjermer L
Int J Chron Obstruct Pulmon Dis; 2017; 12():3211-3219. PubMed ID: 29138549
[TBL] [Abstract][Full Text] [Related]
13. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.
Pela R; Marchesani F; Agostinelli C; Staccioli D; Cecarini L; Bassotti C; Sanguinetti CM
Monaldi Arch Chest Dis; 1998 Jun; 53(3):262-7. PubMed ID: 9785808
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.
Allegra L; Konietzko N; Leophonte P; Hosie J; Pauwels R; Guyen JN; Petitpretz P
J Antimicrob Chemother; 1996 May; 37 Suppl A():93-104. PubMed ID: 8737129
[TBL] [Abstract][Full Text] [Related]
15. Do bacteria cause exacerbations of COPD?
Hirschmann JV
Chest; 2000 Jul; 118(1):193-203. PubMed ID: 10893379
[TBL] [Abstract][Full Text] [Related]
16. Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).
Sportel JH; Koëter GH; van Altena R; Löwenberg A; Boersma WG
Thorax; 1995 Mar; 50(3):249-53. PubMed ID: 7660337
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
18. Multi-site placebo-controlled randomised clinical trial to assess protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.
Clancy RL; Dunkley ML; Sockler J; McDonald CF
Intern Med J; 2016 Jun; 46(6):684-93. PubMed ID: 27009822
[TBL] [Abstract][Full Text] [Related]
19. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.
Stockley RA; O'Brien C; Pye A; Hill SL
Chest; 2000 Jun; 117(6):1638-45. PubMed ID: 10858396
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease.
Möller LV; Timens W; van der Bij W; Kooi K; de Wever B; Dankert J; van Alphen L
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):950-6. PubMed ID: 9517616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
